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ABSTRACT

Methods, systems, and devices to reduce power demands
substantially for current deep brain stimulation DBS using
smart technology type applications. The invention uses miniaturized components that allow integration with the
implanted probe(s) themselves, and includes a skull-sited
housing having all the controls and battery power supply
needed. This avoids implanting obtrusive card-deck size batteries in the chest area and the use of vulnerable wire leads
under the skin from the chest area to connect with the
implanted electrode(s) on the skull, improving comfort. The
Generating of non-continuous pulses on demand of conditions such as the occurrence of a tremor occurs, without
having to continuously run pulses at all times, substantially
increasing life spans over current techniques. Shaped electrodes and their methods further reduce power demands and
efficacy by directing electric fields to focus towards specific
areas and regions of the brain rather than inefficient 360degree emission.
12 Claims, 12 Drawing Sheets
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SPATIAL TEMPORAL DEEP BRAIN
STIMULATION METHODS AND SYSTEMS

door", in a neurological fashion, before dysfunctional brain
signals are sent to the muscles, thereby relieving many symptoms. The advantage of surgical ablation is that it reduces the
reliance on drug therapy with its attendant side effects. The
disadvantage is that the procedure is irreversible. This may
render such patients as unacceptable candidates for newly
discovered techniques/therapies, such as stern cell implantation or viral transport of genome-altered DNA (deoxyribonucleic acid), both of which show promise in helping to
augment or even to regenerate the natural production of
dopamine as well as a number of other substances involved in
neurological disorders.
Certain neurological disorders that produce debilitating
motor symptoms are now being treated with Deep Brain
Stimulation (DBS) through-sknll implanted electrodes see
FIG. 1 below. DBS essentially reversibly alters the local
neurological structure(s) around the tip of an electrode
implanted on the brain with electrical pulses that reduce or
stop disabling symptoms, such as, but not limited to, severe
tremor and rigidity found in Parkinson's disease.
DBS functionally has the advantage of emulating ablation
by changing the firing characteristics of nearby neurons, but it
does so only while the pulsed stimulation persists. Since the
structures remain intact and undamaged, when DBS is turned
"off' these structures reactivate and symptoms return, unless
otherwise treated. Thus, DBS overcomes the chief disadvantage of ablation in that it allows implanted simulators to be
withdrawn later for new techniques, with minimal residual
effects. In 1998, the Federal Drug Administration (FDA)
approved DBS as an alternative for, or as an adjunct to powerful psychoactive drugs (neuro-medicines) burdened with
strong and often unacceptable side effects.
The only FDA approved DBS apparatus is currently being
sold by Medtronic, Inc., 710 Medtronic Parkway, Minneapolis, Minn. 55432-560, see FIGS. 2 and3 below, although other
companies have substantial interests in implantable neurostimulation devices for a variety of neurological disorders,
such as Advanced Bionics, Corp., 127 40 San Fernando Road,
Sylmar, Calif. 91342; see "http://www.advanced bionics.com." However, there are problems with the approved apparatus.
At the very least, the presently approved apparatus is cumbersome and uncomfortable for many in its present form. As
an outgrowth of legacy components from heart "pacemakers," it consists of one or two remote stimulator/battery packs
embedded under muscle tissue in the upper chest area, and
requires subcutaneous leads up along the neck to the skull
entry point. All these components are subject to corrosion and
breakage, as well as to resistance or attacks by the body itself
attempting by encapsulate it or dissolve it, leading to infecti on.
Medtronic currently uses a product called a Soletra™ Neurostimulator (see FIG. 4 below) to generate a continuous
series of electrical pulses, typically at about 2-4 volts, to
electrode(s) implanted in specific brain areas. Neurons, normally operating in the tens of milli-volts range, are massively
over-stimulated by such voltage and temporally altered,
thereby inhibiting the expression of certain motor dysfunctions. Pulse voltage is usually adjusted somewhat depending
on the proximity of the electrode(s) to the targeted area, e.g.,
more voltage is needed for target variations. Typical pulse
rates range around 130-185 pulses/second.
This combination of large amounts of voltage, amperage,
and duty cycle creates a power drain that normally requires a
non-renewable battery replacement in about 3-5 years, at a
price of about $10,000. Many patients turn "off' the stimulation when going to sleep while tremor is quelled, in order to

This is a Divisional of application Ser. No. 10/969,420 filed
Oct. 20, 2004 which claims the benefit of U.S. Provisional
Patent Application 60/586,468 filed on Jul. 8, 2004 and U.S.
Provisional Patent Application 60/512,660 filed on Oct. 20,
2003.
FIELD OF INVENTION
This invention relates to deep brain stimulation (DBS), in
particular to methods, systems, and devices for enhancing
both efficacy and efficiency of "in-vitro" electrical stimulation known to inhibit symptoms of neurological diseases,
disorders, and the like, and utilizes: (a) methods that tailor the
direction and shape of electrical fields towards the area ofbest
effect; (b) systems that interactively trigger stimulation to
terminate the onset of tremors, and such; and (c) devices that
use the aforementioned efficiencies to reduce power and
allow for self-contained miniaturization at the implant site,
thereby improving patient comfort.
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A first line of defense considered for most neurological
disorders is treatment with psychoactive medicines, prior to
any surgical intervention. Psychoactive medicines or drugs
are those capable of acting on the nervous system and affecting mental states and behavior. Many physiological mechanisms are aided by such drugs, but these medicines have
unwanted side effects, drug interactions, and long-term
physiological tolerances that render the drug less effective
overtime.
In the case of Parkinson's disease that serves as the exemplar disorder herein, the underlying etiology is that neurons,
located in the substantia nigra of the mid-brain, for some
unknown reason begin to produce less dopamine. As these
neurons progressively and relentlessly deteriorate over years,
less dopamine dramatically affects the motor control of the
basal ganglia and thus outward behavior and everyday living.
An estimated 1.5 million Parkinson's patients have a visible
cluster of diagnostically significant and debilitating Parkinson's symptoms, typically tremors, stiffness, slowness, and
balance. Patients describe the internal feeling as frozen still in
the "set" stage of the "ready, set, go" sequence that started of
a race.
The "gold" standard treatment for Parkinson's is frequent
daily administration of an indirect dopamine replacement,
L-Dopa, a psychoactive drug that crosses the blood-brain
barrier, and then alters form to produce dopamine as a supplement to the brain's own production. This therapy, while initially quite beneficial, typically can lose much ofits effectiveness over about five years, wherein patients have to take
progressively larger and more frequent doses until eventually
the result becomes inadequate. Without alternative drug
therapies, patients are left to suffer both the ravages of primary symptoms and the manifestations resulting from the
prolonged use of the drug itself, principally the repetitive
spasmodic motions of dyskinesia. More than one million
people endure these symptoms, including such notables as the
Pope, Muhammad Ali, and Billy Graham, while thousands of
others including Michael J. Fox have turned to surgical
approaches.
Past surgical techniques treated symptoms of these diseases by selectively and permanently destroying or ablating
structural areas in the brain. The net effect is to "shut the
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conserve power. Current DBS stimulator(s) are designed to
be turned "off' or "on" using a magnetic-switch placed
briefly near the associated electronics.
Thus, without considering the remote apparatus itself, or
the power requirements of the present design, a goal in this
field should be to reduce stimulation-related side effects and
complications caused by stimulating in the vicinity of the
target. Two key objectives to meeting that goal are for the
surgical implant to hit the center of a targeted cellular region,
often not more than 2 mm across in any direction, and for the
current field to stimulate the appropriate cells for symptom
reduction or cessation, without triggering side effects in adj acent structures.
While the surgical techniques themselves are well documented, the surgery is still a unique combination of art and
science [see Lozano, Andres M. (Ed): Movement Disorder
Surgery: Progress in Neurological Surgery, vol. 15, pp. 202208, Basel, Switzerland: Karger A G, 2000, ISBN 3-80556990-4].
A key to a successful outcome is the precise positioning
and placement of the electrode(s ), aided pre-operatively by
vast improvements in brain imaging techniques, but nevertheless requiring considerable surgical skill and judgment.
Beside normal variations in brain structures themselves adding to the difficulty of targeting, during surgery the brain
moves with each heartbeat, while its size, and position vary
somewhat as a result of the surgical probe itself altering
internal pressure. During the procedure, the use of fluoroscope imaging assists y-z axis positioning, and awakening of
the patient while in the operating room for testing of clinical
signs can reveal and help avoid untoward side effects. However, but the final outcome can only be assessed post-operatively. Results can vary by patient and over time. Some postsurgical adjustment is normally done with electrical
parameters and z-axis prograniming of one or more of the
electrode contacts available on the current DBS electrode, as
is described below, but not to the extent that many physicians
would like and not with respect to the x-y axis.
Current DBS electrodes have four (4) circumferential contacts that radiate current in a 360 degree configuration. This
means that with any degree off-target, or unnecessary stimulation even on target adjacent cells are exposed to current and
potential side effects. While some of these side effects may be
adjustable when electrical parameters are altered, or even
reversible when the stimulation is shut down, but the cost is
decreased efficacy of stimulation on the symptoms. For
example, in sub-thalamic nucleus DBS, stimulation-induced
side effects may include increased dyskinesias, blepharospasm or so called "eyelid-opening apraxia," confusion/
memory disturbances, personality changes, mood changes,
apathy, cognitive changes, dysphonia/dysarthria, and such.
Medtronic Inc. has proposed a "Directional Brain Stimulation and Recording Leads, title, in U.S. Published Patent
Application 2002/0183817 to Van Venrooij et al., which is
incorporated by reference. The proposed technique uses a
"controller" as shown and referenced to FIG. 3 2 for recording
"brain activity signals" to activate electrodes. However, this
technique requires continuously generating pulsed type signals once the electrodes are activated whether or not a brain
type tremor has ended, which would result in needless,
unwanted and potentially-excessive electrical current being
continuously generated inside the brain. The more unnecessary pulse type signals, the more undesirable side effects to
the patient, for example, in thalamic DBS, stimulation-induced side effects may include paresthesias, muscular
cramps, dystonia, dizziness, dysarthria, gait and balance dis-

turbances, limb ataxia, impaired proprioception, and
decreased fine motor movements.
Additionally, this technique would require excessive
power to operate, which is not only expensive since battery
power supplies would need to be regularly replaced but also
require large card-deck size batteries that must be mounted
inside of the patient's upper chest area. This proposed
Medtronic technique would also be prone to circuit problems
since the electrodes would be simultaneously operating as
both transmitters and sensors, causing excessive and unnecessary power drain, shortening the lifespan of any batteries
being used as well as increasing the costs for replacing the
batteries.
According to the Movement Disorder Society© 2002,
"Deep brain stimulation for the alleviation of movement disorders and pain is now an established therapy. However, very
little has been published on the topic ofhardware failure in the
treatment of such conditions irrespective of clinical outcome.
Such device-related problems lead to significant patient morbidity and increased cost of therapy in the form of prolonged
antibiotics, in-patient hospitalization, repeat surgery, and
device replacement [Joint, C., Nandi, D., Parkin, S., Gregory,
R., and Aziz, T. Hardware-Related Problems ofDeep Brain
Stimulation. Movement Disorders, Vol. 17, Suppl. 3, 2002,
pp. S175-S180.]
Thus, the need exists for solutions to the problems encountered in the prior art.
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SUMMARY OF THE INVENTION
A first objective of the present invention is to provide for
deep brain stimulation (DBS) methods, systems and devices
that avoid implanting large card-deck size batteries remotely
in the chest area and the use of vulnerable wire leads under the
skin from the chest area to connect with the implanted electrode on the skull.
A second objective of the present invention is to provide for
deep brain stimulation (DBS) methods, systems and devices
that allow for substantially all electronics including but not
limited to an on-site battery pack to be located at or near the
implanted electrodes on the skull.
A third objective of the present invention is to provide for
deep brain stimulation (DBS) methods, systems, and devices
that can use substantially less power than current DBS techniques and apparatus.
A fourth objective of the present invention is to provide for
deep brain stimulation (DBS) methods, systems and devices,
that do not generate a continuous series ofun-synchronized
pulses that are continuously generated whether they are
needed or not.
A fifth objective of this invention is to provide for deep
brain stimulation (DBS) methods, systems and devices, to
generate pulses on demand. Specifically, inhibiting pulse(s)
can be interactively triggered by the onset of each unwanted
electro-physiologically signaled event, such as at the beginning of a tremor.
A sixth objective of the present invention is to provide for
deep brain stimulation (DBS) methods, systems and devices
that are more compact, easier to use and last longer than
current DBS techniques, thereby improving patient comfort.
A seventh objective of the present invention is to provide
for shaped electrodes and methods by using the electrode
contacts in deep brain stimulation (DBS) methods, systems
and devices, that orient configured electrical fields to specific
points, preferentially directing current a targeted cellular
region and facilitating the clinical effect. The best direction of

US 8,032,231 B 1
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the shaped current can be determined intra-operatively
through recordings and clinical testing along the "X-Y"
plane.
An eighth objective of the present invention is to use
shaped electrodes in deep brain stimulation (DBS) methods,
systems and devices, in order to decrease off-target current
stimulation, thereby minimizing or eliminating exposure to
adjacent cellular regions that produce side effects.
A ninth objective of the present invention is to use the
decreased electrical "aperture" of shaped electrodes in deep
brain stimulation (DBS) methods, systems and devices, in
order to maintain current density on the target region, but with
less overall current flow and less battery drain over time.
Methods, systems and devices are provided for deep brain
stimulation (DBS), that can include providing a pulse stimulator with battery supply and controls within one unit, imbedding the single unit on a head of a user, and generating a single
treatment pulse from the stimulator to the brain of the user, the
single pulse being generated on demand of a sensed initiation
of an impulse burst from a condition. Another single pulse can
be generated upon occurrence of a follow-up sensed impulse
burst. The impulse bursts can come from a detected brain
activity condition such as those associated with tremors, and
the like.
The methods, systems and devices can also include providing the battery power supply solely in a compact skullmounted cylindrical disc cap without implanting of batteries
in a chest area of the user and avoiding any use of wires under
skin from the chest area to connect to the stimulator, mounted
as a skull cap with the top cap disc cover and the bottom
cylindrical disc housing underneath and covered by the scalp,
with a single opening in the skull for the lead line, further
improving patient comfort.
Controls can also include filtering sensed signals from
electrode sensors to a noise amplitude filter, followed by
counting impulses in the filtered signals with an impulse
counter, and then triggering the single treatment pulse when a
selected threshold of the counted impulses has been reached.
Furthermore, controls can allow for shutting off the noise
amplitude filter, and the impulse counter when the triggering
of the single treatment pulse has been initiated.
Various types of directional components can be provided
for directing the treatment signals to effected areas of the
brain of the user.
Further objects and advantages of this invention will be
apparent from the following detailed description of the presently preferred embodiments, which are illustrated schematically in the accompanying drawings.

FIG. 7b illustrates the axial views of the four shaped electrodes of FIG. 7a with respective projected fields.
FIG. Sa shows a recording trace graph of neuronal impulse
bursts in mill volts verses time that can occur with an
untreated patient.
FIG. Sb shows a trace graph of associated tremor displacement for FIG. Sa in millimeters verses time that can occur
with the untreated patient.
FIG. 9 shows an exemplary flow chart of a triggering algorithm steps that can be used with the invention.
FIGS. 10, lOa and lOb shows a layout of the electronic
components that can be used in the apparatus of FIGS. Sa, Sb,
6 along with the triggering algorithm of FIG. 9.
FIG. lla shows a trace graph of the neuronal impulse
bursts in milli-volts verses time of a patient being treated with
a Medtronic type (prior art) technique.
FIG. llb shows a trace graph of the associated tremor
displacement for FIG. llb verses time of the patient being
treated with the Medtronic type (prior art) technique.
FIG. llc shows the continuing pulse train that occurs with
the Medtronic type (prior art) technique which causes the
trace graphs of FIGS. lla-llb.
FIG. 12a shows a trace graph of the neuronal impulse
bursts in milli-volts verses time of a patient being treated from
being treated by the subject invention.
FIG. 12b shows a trace graph of the associated tremor
displacement for FIG. 12a verses time of the patient being
treated by the subject invention.
FIG.12c shows the single pulses that occur with the subject
invention technique which results in the trace graphs of FIGS.
l2a-l2b.
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BRIEF DESCRIPTION OF THE FIGURES
FIG. 1 shows a deep brain stimulation (DBS) apparatus of
the prior art.
FIG. 2 is a front view of the current prior art DBS of FIG.
1.
FIG. 3 shows DBS head-mounting details of the prior, art
of FIGS. 1-2.
FIG. 4 shows another prior art product device.
FIG. Sa shows an open view of a miniaturized integrated
battery/stimulator apparatus of the subject invention.
FIG. Sb shows a closed view of the apparatus of FIG. Sa.
FIG. 6 shows the novel invention apparatus of FIGS. Sa-Sb
utilized in a head mounted application.
FIG. 7a shows enlarged side views of four shaped electrodes with projected fields used in the apparatus of FIGS. Sa,
Sb and 6.
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DESCRIPTION OF THE PREFERRED
EMBODIMENTS
Before explaining the disclosed embodiments of the
present invention in detail it is to be understood that the
invention is not limited in its applications to the details of the
particular arrangements shown since the invention is capable
of other embodiments. Also, the terminology used herein is
for the purpose of description and not of limitation.
This invention provides methods, systems and devices to
reduce power demands substantially for DBS (deep brain
stimulation), allowing for miniaturized type components to
be integrated with the implanted probe(s) themselves, see
FIGS. Sa, Sb, 6and10. The invention avoids implanting large
and cumbersome card-deck size batteries in the chest area and
the use of vulnerable wire leads under the skin from the chest
area to connect with the implanted electrode(s) on the skull.
Notably, the remote stimulator/battery with its associated
wiring are the chief source of complaints in the use of this
technique. Other advantages ofthis invention are also apparent.
The invention substantially differs from that used in current techniques. Rather than generating a continuous series of
un-synchronized pulses that act whether needed or not, pulses
can be generated on demand. Specifically, inhibiting pulse(s)
can be interactively triggered by the onset of an unwanted
electro-physiologically signaled event, such as the beginning
of a tremor. The same electrode( s) that now serves as a oneway input also can serve as a bi-directional conduit to sense
the electrical beginnings of the event itself as well as delivering the pulse(s). Thus, with appropriately tailored, triggering algorithms, a preferred example of which is described
below in reference to FIG. 9, an inhibiting pulse can be timed
for delivery so as to suppress the event's full expression.

US 8,032,231 B 1
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Using this approach, power drain reductions of conservatively 85% or more are achievable, with the percentage
depending on the neurological events of interest. For
example, most tremors are less than approximately 10 tremor
cycles per second, and can be far less when the tremor is
interrupted by another intentional activity such as purposeful
movement, as in the case of Parkinson's disease. Thus, the
constant power drain can be reduced from approximately 150
stimulating pulses/second using the current techniques
described in the prior art to now to as little as one stimulating
pulse counteracting each tremor onset using interactive triggering.
Even greater power reductions are possible for "lower frequency" tremor, such as Essential tremor at approximately 5
to approximately 7 tremor cycles/ second, or "low-frequency"
Parkinson tremor at approximately 3 to approximately 5
tremor cycles/second.
With dramatically reduced power demands for DBS, this
invention then allows for miniaturized components to be integrated with the skull cap attachment to the implanted probe(s)
themselves, as shown in FIGS. Sa, Sb, 6and10.
FIG. Sa shows an open view of a miniaturized integrated
battery/stimulator apparatus 1 of the subject invention. FIG.
Sb shows a closed view of the apparatus 1 of FIG. Sa in a
cylindrical disc housing where the top cap covers the bottom
cylindrical disc of the disc housing. FIG. 6 shows the novel
invention apparatus 1 of FIGS. Sa-Sb utilized in a head
mounted application with the top cap disc cover and the
bottom cylindrical disc housing mounted as a skull cap underneath and covered by the scalp with the imbedded probe
extending downward from beneath a central portion of the
cylindrical housing through the skull and into the brain. As
shown in FIG. 6, the novel size of the cylindrical disc housing
and the cap mount application is compact and easier to use
than the prior art, and is not uncomfortable and cumbersome
to the user as in the prior art. The compact cylindrical disc
housing with miniaturized components does not cause a
noticeable protrusion above the scalp line and existing hair of
the user.
Referring to FIGS. Sa-Sb and 6, the hole cap 20 can include
a top cover 20T, and bottom cylindrical disc housing 20B to
house components 100 (which are described and shown in
greater detail in reference to FIG. 10). Underneath the cap 20
can be a lead line 30, and approximately four (4) directional
electrodes 40, SO, 60 and 70 attached thereon. FIG. 7a shows
enlarged side views of four shaped electrodes with projected
fields Pl, used in the apparatus of FIGS. Sa, Sb and 6. FIG. 7b
illustrates the axial views of the four shaped electrodes of
FIG. 7a with respective projected fields.
Referring to FIGS. 6, 7a and 7b, the electrodes 40-70 on the
lead 3 0 can include a non-conducting material, such as but not
limited to insulating material, and the like, on one side or on
a portion of the electrode. Examples, of non-conducting
material can include but are not limited to rubbers, elastamers, plastics, coated metals, and the like, and combinations thereof, and the like.
This nonconductive material can also be used to help direct
electrical field emissions to one side or to more specific
regions, and/or points, rather than to a 360-degree emission.
The invention can include a lead 30 can having a single
electrode with a nonconductive surface region.
Alternatively, more than one electrode can be used an the
lead in series to one another. The nonconductive surface
region can be applied on the same side of the electrodes, or to
different side surface portions of the electrodes as needed.
Additionally, different combinations can be used. For

example, an upper electrode can emit up to 360 degrees while
other electrodes are directed to emit in specific regions and/or
points.
Additionally, circuitry can be added to control which electrodes are being emitted at selected time periods, and the like.
For example, electrodes can be further programmed with a
microprocessor, to activate simultaneously and/or sequentially, and/or staggered and/or over different combinations,
and the like. The invention can use directional type electrodes, such as those shownanddescribedinreferenceto U.S.
Published Patent Application 2002/0183817 to Van Venrooij
et al., which is incorporated by reference.
The miniaturized implantable electrode apparatus and
stimulation systems can also include those described in
United States Patent Application 20030023297, to Byers et
al. filed on Jan. 30, 2003, which is incorporated by reference.
This reference describes an eyelid stimulation system and
circuitry that causes a paralyzed eyelid to close or open by
passing an electrical stimulating current to a nerve.
The invention can be used to treat brain impulse bursts and
the resultant physical extremity tremors that result therefrom.
FI GS. Sa and Sb represent untreated brain impulse bursts and
resultant physical extremity tremor outcome that are
untreated. FIG. Sa shows the recording of impulse bursts
from the brain B, that results from the leads 30 that are
connected to the electrodes 40-70 (of the apparatus ofFIG. 6).
The large amplitude bursts represent the impulses that result
in the tremors (impulses from brain to effected extremity).
FIG. Sb represents an extremity that is being affected by the
impulse (here for example, a single index right hand finger).
A laser measuring sensor was aimed at the index finger to
record the results shown in FIG. Sb. For example, a plus 5 mm
apex reading would represent the finger moving forward from
a horizontal plane, and -5 mm represents the finger moving
aft in the horizontal direction.
The invention can use a triggering algorithm to selectively
activate electrodes and treat effected parts of the brain where
impulse bursts occur. FIG. 9 shows an example flow chart of
a triggering algorithm steps that can be used with the invention. The triggering algorithm can take a number of forms or
be adaptive, based on patient neuro-generative responses. In a
simple illustrative form, not intended to be limiting, triggering sensing can be based on exceeding a threshold-firing rate
measured in impulses/second.
FIG. 9 shows an exemplary triggering algorithm 200 for
using the electrodes 40-70 of the preferred embodiment
shown in the preceding figures that switches back and forth
between a sensing mode and transmitting mode. In the first
step 210, signals coming from leads 30 from the microelectrodes 40-70 in the implant receive a signal from the
electrodes 40-70 the first left trace signal from FIG. Sa) can be
passed through a noise amplitude filter 220 for example an
high pass amplitude filter cutting off a low frequency of for
example everything below approximately 20 mill volts is
filtered out). Next during step 230, the filtered signal goes to
an impulse counter, such as a clock counter which can count
the number of impulses passing through, which can be represented in impulses per second. Next step 240, has an
impulse firing threshold type circuit that can be used that
filters out false alarms and allows for a selected threshold,
such as for example, 5 impulses within 50 milli-seconds,
would trigger the generator in step 2SO to send a generated
pulse SP back down the signal leads 30 to the electrodes
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When the generator is triggered, a signal can also be sent
(along line Off) to simultaneously shut off the sensing mode
of the electrodes, allowing the electrodes to be in a transmit-
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ting mode state. Sensing mode parameters of the electrodes
40-70 can be in approximately 20 to approximately 60 millivolts, while the transmitting/triggering range of the electrodes 40-70 can be approximately 2 to approximately 4 volts.
The novel triggering algorithm 200 allows the electrodes
40-70 to be switched back and forth between transmitting and
sensing modes without overloading the circuit components,
and thus maximizing power usage during operation.
Once triggered, stimulation blocking continues until firing
impulse firing rate drops below the critical threshold value.
The sensing and stimulation can use the same micro-electrode leads, alternatively, wherein the sensing circuitry first
uses an impulse counter/clock, then if threshold is exceeded,
circuit switching turns "off' the sensor and turns "on" the
stimulator for one or more pulses.
Various triggering algorithms can be developed for effective symptom suppression with animal studies. However, the
safety of this invention's procedure has already been established for humans with continuous and higher pulse rates
through FDA (Food and Drug Administration) approval. Further, a market also exists for electronic retrofit to thousands of
patients who have already been implanted previously, without
further brain surgery since the existing DBS electrodes can
serve as a two-way bi-directional conductor.
In vitro testing of this approach also can be possible using
current systems by sensing electro-magnetic forces from subcutaneous wires of a neurological event onset, such as the
beginning of a tremor. These signals, then in tum, can allow
the triggering of the existing magnetic switch for turn "off'
and "on".
Other types of triggering mechanisms can include those
described in U.S. Pat. Nos. 6,539,263 to Schiff; 6,366,813 to
DiLorenzo; 6,301,492 to Zonenshayn; 6,038,480 to Hrdlicka
et al.; 5,833,709 to Rise et al.; 5,716,377 to Rise et al.; and
5,707,396 to Benabid, which are all incorporated by reference. Additionally, US Patent Applications 20030181954 to
Rezai; 20030085684 to Tsukamoto et al.; and 20020188330
to Frans et al., which are all incorporated by reference,
FIGS. 10, lOa and lOb shows a layout of the electronic
components that can be used in the apparatus of FIGS. Sa, Sb,
6 along with the triggering algorithm of FIG. 9. Referring to
FIGS. Sa, Sb, 6, 10, lOa and lOb, the cap 20 can include
miniaturized components that include a battery type power
supply 110, which provides power to a stimulation generator
controller 120, which is triggered by a triggering switch 130
which receives signals from a sensing circuit 140 all of which
are connected to electrodes 40-70 on lead line 30 that is
implanted into the skull 310 of the patient 300.
The invention can make use of ultra-miniature batteries
110 such as those, manufactured by Advanced Bionics Corp.,
which are only about 1!3s the size of a standard AA battery and
now serve medical implants by emitting electrical micropulses that stimulate nearby nerves. These tiny batteries, or
"Bions," can also be can be programmed from outside the
body for strength and frequency of the stimulation, and wirelessly recharged with an electrical field. The use of these
ultra-miniature batteries would avoid both a chief source of
complaints; the remotely implanted card-deck sized stimulator/battery [about 60 by about 80 by about 15 mm] in the chest
area, its replacement, while also avoiding problems associated with vulnerable wire leads under the skin from the chest
area to connect with, the implant on the skull.
The Stimulation Generator Controller 120 can be a solidstate device such as the one shown and described in the
Medtronic's Model 3628 cited 0093 of U.S. Published Patent
Application No. 2002/0183817 to Van Venrooij et al., which
is incorporated by reference. Trigger Switch 130 can be a

common mini-double throw "on-off' and "off-on" electronic
switch, triggering based on sensing circuit threshold. The
Sensing Circuit 140 can be a common solid-state impulse
counter-clock, e.g. mini-version of cardiac-alarm, monitoring electrical impulses to heart
The circuits are powered by miniature battery 110 as
shown in FIG. lOb. The sensing circuit 140 can include the
noise amplitude filter 220 and impulse counter 230 of FIG. 9.
The trigger switch 130 is activated when threshold circuit 240
of FIG. 9 is exceeded to tum "off' the sensor input and tum
"on" the stimulation generator 120. This is reversed when the
impulse is blocked, dropping below threshold.
The components to run the novel invention can be fit into a
space of approximately 60 mil by 15 mil compared to prior
art. Conservatively less than 50% of the current 60 by about
80 by about 15 mm in a plastic skull-cap implant see FIG. 6.
The invention, can be less expensive than the current techniques, since no surgery tunneling down the neck into the
chest area is needed for the battery cards, and thus no repairs
or surgery for those components-which currently about $10,
000 every 3-5 years.
Benefits of using the novel triggering algorithm of FIG. 9
and apparatus components of FIGS. Sa, Sb, 6, 10 and FIGS.
lla-llc, 12a-12c.
FIG. lla shows a trace graph of the neuronal impulse
bursts in mill volts verses time of a patient being treated with
a Medtronic type (prior art) technique such as the one shown
and described in reference to U.S. Patent Application Publication 2002/0183817 to Van Venrooij et al., which is incorporated by reference. FIG. llb shows a trace graph of the
associated tremor displacement for FIG. llb verses time of
the patient being treated with the Medtronic type (prior art)
technique. FIG. llc shows the continuing pulse train that
occurs with the Medtronic type (prior art) technique which
causes the trace graphs of FIGS. lla-llb.
Referring to FIGS. lla-llc, results in a continuing pulse
train (FIG. llc) in order to cause the effects of no impulse
bursts (FIG. lla) and no resultant physical tremors (FIG.
llb ).As described in the background section of this invention
this technique requires continuously generating pulsed type
signals once the electrodes are activated whether or not a
brain type tremor has ended, which would result in needless
and excessive, unwanted and potentially dangerous electrical
current being continuously generated inside the brain. The
more unnecessary pulse type signals, the more undesirable
side effects to the patient.
Additionally, the technique proposed in this patent application publication would require excessive power to operate,
which are not only expensive since battery power supplies
would need to be constantly replaced but also require large
card size batteries that must be externally mounted outside of
a patient or mounted inside of the upper chest or be constantly
connected to an external power supply. This proposed
Medtronic technique would also be prone to short circuit
since the electrodes would be simultaneously operating as
both transmitters and sensors, which also causes excessive
and unnecessary power drain, which also shortens the
lifespan of any batteries being used as well as increase the
costs for replacing the batteries.
FIG. 12a shows a trace graph of the neuronal impulse
bursts in mill volts verses time of a patient being treated from
being treated by the subject invention described above. FIG.
l2b shows a trace graph of the associated tremor displacement for FIG. 12a verses time of the patient being treated by
the subject invention. FIG. 12c shows the single pulses that
occur with the subject invention technique which results in
the trace graphs of FIGS. 12a-12b.

10

15

20

25

30

35

40

45

50

55

60

65

US 8,032,231 B 1
11
Referring to FIGS. 12a-12c, the invention causes single
spaced apart pulses to occur over greater periods of tithe,
where each pulse occurs on-demand, and not as a continuous
series of pulses. As shown by FIG. 12a, the initial impulse
burst and subsequent impulse bursts have long delay time
periods there between, which can result in substantially
reduced or eliminated tremors resulting therefrom, FIG. llb.

12

The invention claimed is:
1. A system for both sensing a single brain tremor and for
providing deep brain stimulation (DBS) by a single treatment
pulse, consisting of:
a single cylindrical disc housing consisting of a single
bottom and side edges extending from the bottom, and a
single removable cylindrical top cover with perimeter
sides which overlap the side edges of the housing, so that
The novel invention allows for less undesirable electrical
the cylindrical top cover covers a single compartment
current to be generated within the brain, less side effects that 10
inside of the cylindrical disc housing, the single cylinresult therefrom, less power consumption as well as other
drical disc housing having a height of approximately 15
apparent benefits. The novel invention can use small batteries
millimeters, the single cylindrical disc housing adapted
that were not able to be used in the prior art systems and
to be mounted as a cap on a sknll of a user, and not being
techniques, and also results in power supplies that require less
implanted beneath the skull of the user;
replacements as well. The novel invention is able to eliminate 15
a single elongated lead line extending beneath a center
portion of the bottom of the single cylindrical disc housthe need for large and cumbersome card type batteries or
ing having a plurality of electrodes thereon, the elecexternal power supplies, and results in a better system for
trodes each being used to both sense a single brain
treatment.
tremor from an effected part of a brain and generate
Differences between the subject invention and that
pulses therefrom, only the single elongated lead line
20
described in the Medtronic technique shown in U.S. Patent
being adapted to be implanted into only a single opening
Application Publication 2002/0183817 to Van Venrooij et al.
in a skull of a head of a user while the single cylindrical
are compiled in Table 1.
disc housing remains mounted as a cap on top of the
skull of the user;
TABLE 1
25
a pulse stimulator inside of the compartment of the cylindrical disc housing, the pulse stimulator only becoming
Comparison of prior art (Medtronic) and Invention.
activated upon sensing of the single brain tremor from
Medtronic
Attribute
Invention
one of the electrodes on the single lead line, the pulse
stimulator not generating any pulses when a tremor is
Sensing
Loss of Effectiveness
Single Event
30
not being sensed, the pulse stimulator includes a pulse
Brain "Activity"
Initial Impulse Burst
Trigger
Objective
Select Electrodes
Stop Single Tremor
generator for generating single spaced apart non-conNormally-On
Normally-Off
Stimulator
tinuous pulses upon initial occurrence of the single brain
No "off'
Only "on" as needed
Power
tumor tremor sensed from the one electrode on the single
(continuing pulses)
(individual pulse)
implanted lead line;
Small Battery
Large Battery
Limited
Extended
Power Lifespan
sensing detection circuitry solely located inside of the
35
Skull-Mounted in Cap
Battery Mounting "Implantable"
compartment of the cylindrical housing for sensing the
Side Effects
Continuous electrical current Limited Electrical Current
single brain tremor from the one electrode on the single
lead line, the one electrode sensing the brain tremor
produced from the effected part of the brain is used for
Besides circuitry miniaturization, by triggering pulse gentreating the effected part of the brain that produces the
eration only when needed, fewer pulses per second also can 40
brain tremor;
reduce some of the mild, but known side effects of DBS, and
controls for the pulse stimulator that are all solely located
the timed delivery also can delay the onset of the next event by
inside of the compartment of the cylindrical disc housphysiological feedback, that is also known to be effective
ing, the controls for activating the pulse stimulator only
against a known clinical phenomena Parkinson's Disease.
45
upon the sensing of the single brain tremor from the one
Other advantages can also be realized. The timed pulse
electrode on the single lead line, the pulse stimulator for
feedback speculatively could induce the brain to adaptively
generating a single treatment pulse only upon the occurrence of the sensed single tremor, the controls for deacalter actual neural circuitry, allowing a further reduction of
tivating the pulse stimulator so that no pulses are being
pulse rate and even more efficiency or even better help reduce
generated when a tremor is not being sensed from the
symptoms naturally, just as brain circuitry is known to be 50
one electrode, the electrodes on the single lead line being
altered by experience.
connected to the controls for both sensing brain activity
While the invention has been described for use with tremand for generating the single treatment pulse upon actiors, the invention can have applicability to other medical
vation of the pulse stimulator, wherein the single treatapplications, such as but not limited to movement disorders 55
ment pulse is generated after the single brain tremor is
and cardiac dysfunctions, but extends to include other neurodetected by the one electrode; and
logical diseases and disorders such as epilepsy, psychiatric
a battery power supply for the stimulator solely located
and behavioral dysfunctions such as schizophrenia and druginside the cylindrical disc housing for providing all
induced symptoms and the like.
power for the pulse stimulator and all power for the
While the invention has been described, disclosed, illus- 60
controls, wherein the controls control the battery power
trated and shown in various terms of certain embodiments or
supply to supply power to the pulse stimulator only upon
modifications which it has presumed in practice, the scope of
the sensing of the single tremor, and wherein the controls
invention is not intended to be, nor should it be deemed to be,
tum off the pulse stimulator after sensing detection cirlimited thereby and such other modifications or embodiments
cuitry has been turned on, wherein the cylindrical disc
shaped housing eliminates implanting of any batteries in
as may be suggested by the teachings herein are particularly 65
reserved especially as they fall within the breadth and scope
the chest area and the use of any other wires under the
of the claims here appended.
skin from the chest area to connect with the implanted
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electrodes, and wherein no other lead lines and no other
wires are connected to the single cylindrical disc housing and the single implanted lead line extending below
the single cylindrical disc housing, and only the single
cylindrical disc housing and the single implantable lead
line are used for both sensing and for providing deep
brain stimulation (DBS), the single cylindrical disc
housing being positioned as the cap on top of the skull of
the user and adapted to cover the cylindrical disc housing with the scalp.
2. The system of claim 1, wherein the controls include:
a noise amplitude filter for filtering sensed signals from the
electrodes that are below approximately 20 mill-volts;
an impulse counter for counting impulses in the filtered
signals in impulses per second; and
a trigger switch for triggering a single treatment pulse
when a selected threshold of the counted impulses has
been reached, wherein the controls shut off the noise
amplitude filter and the impulse counter when the triggering of the single treatment pulse has been initiated.
3. The system of claim 1, wherein the cylindrical disc
housing includes:
dimensions of 60 millimeters in diameter.
4. The system of claim 3, wherein the battery power supply
includes:
miniature batteries that are each approximately 1/3s of an
AA battery.
5. The system of 4, wherein the plurality of electrodes
includes:
only four electrodes on the single implantable lead line.
6. The system of claim 5, wherein the only four electrodes
includes:
one electrode that emits in an approximately 360 degree
field about the single implantable lead line; and
three electrodes that each emit in limited selected directional regions.
7. The system of claim 2, wherein the controls include:
sensing mode of the electrodes are approximately 20 to
approximately 60 milli-volts; and
triggering range of the electrodes are approximately 2 to
approximately 4 volts.
8. The system of claim 1, wherein the battery is wirelessly
recharged by an external electric field.
9. A system for both sensing a single brain tremor and for
providing deep brain stimulation (DBS) by a single treatment
pulse, consisting of:
a single cylindrical disc housing consisting of a single
bottom and side edges extending from the bottom, and a
single removable cylindrical top cover with perimeter
sides which overlap the side edges of the housing, so that
the cylindrical top cover covers a single compartment
inside of the cylindrical disc housing, the single cylindrical disc housing having a height up to approximately
15 millimeters and a diameter of approximately 60 millimeters, the single cylindrical disc housing adapted to
be mounted as a cap on a skull of a user, and not being
implanted below the skull of the user;
a single elongated lead line extending beneath a center
portion of the bottom of the single cylindrical disc housing having a plurality of electrodes thereon, the electrodes each being used to both sense a single brain
tremor and generate pulses therefrom, only the single
elongated lead line being adapted to be implanted into
only a single opening in a skull of a head of a user while
the single cylindrical disc housing remains mounted as a
cap on top of the skull of the user;
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a pulse stimulator inside of the compartment of the cylindrical disc housing, the pulse stimulator only becoming
activated upon sensing of the single brain tremor from
one of the electrodes on the single lead line, the pulse
stimulator not generating any pulses when a tremor is
not being sensed, the pulse stimulator includes a pulse
generator for generating single spaced apart non-continuous pulses upon initial occurrence of the single brain
tumor tremor sensed from the one electrode on the single
implanted lead line;
sensing detection circuitry solely located inside of the
compartment of the cylindrical housing for sensing the
single brain tremor from the one electrode on the single
lead line;
controls for the pulse stimulator that are all solely located
inside of the compartment of the cylindrical disc housing, the controls for activating the pulse stimulator only
upon the sensing of the single brain tremor from the one
electrode on the single lead line, the pulse stimulator for
generating a single treatment pulse only upon the occurrence of the sensed single tremor, the controls for deactivating the pulse stimulator so that no pulses are being
generated when a tremor is not being sensed from the
one electrode, the electrodes on the single lead line being
connected to the controls for both sensing brain activity
and for generating the single treatment pulse upon activation of the pulse stimulator, wherein the single treatment pulse is generated after the single brain tremor is
detected by the one electrode, the one electrode sensing
the brain tremor produced from the effected part of the
brain is used for treating the effected part of the brain
that produces the brain tremor, the controls include:
a noise amplitude filter for filtering sensed signals from
the electrodes,
an impulse counter for counting impulses in the filtered
signals in impulses per second,
a trigger switch for triggering a single treatment pulse
when a selected threshold of the counted impulses has
been reached, wherein the controls shut off the noise
amplitude filter and the impulse counter when the
triggering of the single treatment pulse has been initiated, and
an impulse firing threshold circuit for filtering out false
alarms and allowing for a selected threshold value;
and
a battery power supply for the stimulator solely located
inside the cylindrical disc housing for providing all
power for the pulse stimulator and all power for the
controls, wherein the controls control the battery power
supply to supply power to the pulse stimulator only upon
the sensing of the single tremor, and wherein the controls
stop supplying power to the pulse stimulator after sensing detection circuitry has been turned on, wherein the
cylindrical disc shaped housing eliminates implanting of
any batteries in the chest area and the use of any other
wires under the skin from the chest area to connect with
the implanted electrodes, and wherein no other lead lines
and no other wires are connected to the single cylindrical
disc housing and the single implanted lead line extending below the single cylindrical disc housing, and the
single cylindrical disc housing and the single implantable lead line extending below the single cylindrical disc
housing, and only the single cylindrical disc housing and
the single implantable lead line are used for both sensing
and for providing deep brain stimulation (DBS), the
single cylindrical disc housing being positioned as the
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cap on top of the skull of the user and adapted to cover
the cylindrical disc housing with the scalp.
10. The system of claim 9, wherein the noise amplitude
filter is filtering sensed signals from the electrodes that are
below approximately 20 mill-volts.
11. The system of claim 10, wherein the controls include:
a sensing mode of the electrodes being approximately 20 to
approximately 60 milli-volts; and

a triggering range of the electrodes being approximately 2
to approximately 4 volts.
12. The system of claim 9, wherein the threshold value is
approximately 5 impulses within approximately 50 milliseconds.
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